Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids

Summary: We developed a modified protocol, based on differential ultracentrifugation (dUC), to isolate extracellular vesicles and particles (specifically exomeres) (EVPs) from various human and murine sources, including cell lines, surgically resected tumors and adjacent tissues, and bodily fluids,...

Full description

Bibliographic Details
Main Authors: Linda Bojmar, Han Sang Kim, Gabriel C. Tobias, Fanny A. Pelissier Vatter, Serena Lucotti, Kofi Ennu Gyan, Candia M. Kenific, Zurong Wan, Kyung-A Kim, DooA Kim, Jonathan Hernandez, Virginia Pascual, Todd E. Heaton, Michael P. La Quaglia, David Kelsen, Tanya M. Trippett, David R. Jones, William R. Jarnagin, Irina R. Matei, Haiying Zhang, Ayuko Hoshino, David Lyden
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166720302124
_version_ 1819163698386698240
author Linda Bojmar
Han Sang Kim
Gabriel C. Tobias
Fanny A. Pelissier Vatter
Serena Lucotti
Kofi Ennu Gyan
Candia M. Kenific
Zurong Wan
Kyung-A Kim
DooA Kim
Jonathan Hernandez
Virginia Pascual
Todd E. Heaton
Michael P. La Quaglia
David Kelsen
Tanya M. Trippett
David R. Jones
William R. Jarnagin
Irina R. Matei
Haiying Zhang
Ayuko Hoshino
David Lyden
author_facet Linda Bojmar
Han Sang Kim
Gabriel C. Tobias
Fanny A. Pelissier Vatter
Serena Lucotti
Kofi Ennu Gyan
Candia M. Kenific
Zurong Wan
Kyung-A Kim
DooA Kim
Jonathan Hernandez
Virginia Pascual
Todd E. Heaton
Michael P. La Quaglia
David Kelsen
Tanya M. Trippett
David R. Jones
William R. Jarnagin
Irina R. Matei
Haiying Zhang
Ayuko Hoshino
David Lyden
author_sort Linda Bojmar
collection DOAJ
description Summary: We developed a modified protocol, based on differential ultracentrifugation (dUC), to isolate extracellular vesicles and particles (specifically exomeres) (EVPs) from various human and murine sources, including cell lines, surgically resected tumors and adjacent tissues, and bodily fluids, such as blood, lymphatic fluid, and bile. The diversity of these samples requires robust and highly reproducible protocols and refined isolation technology, such as asymmetric-flow field-flow fractionation (AF4). Our isolation protocol allows for preparation of EVPs for various downstream applications, including proteomic profiling.For complete details on the use and execution of this protocol, please refer to Hoshino et al. (2020).
first_indexed 2024-12-22T17:48:16Z
format Article
id doaj.art-7d8e9011528240a59bd11296b6bfba77
institution Directory Open Access Journal
issn 2666-1667
language English
last_indexed 2024-12-22T17:48:16Z
publishDate 2021-03-01
publisher Elsevier
record_format Article
series STAR Protocols
spelling doaj.art-7d8e9011528240a59bd11296b6bfba772022-12-21T18:18:15ZengElsevierSTAR Protocols2666-16672021-03-0121100225Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluidsLinda Bojmar0Han Sang Kim1Gabriel C. Tobias2Fanny A. Pelissier Vatter3Serena Lucotti4Kofi Ennu Gyan5Candia M. Kenific6Zurong Wan7Kyung-A Kim8DooA Kim9Jonathan Hernandez10Virginia Pascual11Todd E. Heaton12Michael P. La Quaglia13David Kelsen14Tanya M. Trippett15David R. Jones16William R. Jarnagin17Irina R. Matei18Haiying Zhang19Ayuko Hoshino20David Lyden21Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58183, SwedenChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, KoreaChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, BrazilChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USAChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USAChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; Tri-Institutional PhD Program in Computational Biology and Medicine, New York, NY, USAChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USAChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USAYonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, KoreaYonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, KoreaHepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USADepartment of Pediatrics, Weill Cornell Medicine, New York, NY, USA; Drukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USADepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Pediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Pediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USAThoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAHepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USAChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; Corresponding authorChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan; Corresponding authorChildren’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA; Corresponding authorSummary: We developed a modified protocol, based on differential ultracentrifugation (dUC), to isolate extracellular vesicles and particles (specifically exomeres) (EVPs) from various human and murine sources, including cell lines, surgically resected tumors and adjacent tissues, and bodily fluids, such as blood, lymphatic fluid, and bile. The diversity of these samples requires robust and highly reproducible protocols and refined isolation technology, such as asymmetric-flow field-flow fractionation (AF4). Our isolation protocol allows for preparation of EVPs for various downstream applications, including proteomic profiling.For complete details on the use and execution of this protocol, please refer to Hoshino et al. (2020).http://www.sciencedirect.com/science/article/pii/S2666166720302124Cell cultureCell isolationCell MembraneExosomesExomeresExtracellular vesicles and particles
spellingShingle Linda Bojmar
Han Sang Kim
Gabriel C. Tobias
Fanny A. Pelissier Vatter
Serena Lucotti
Kofi Ennu Gyan
Candia M. Kenific
Zurong Wan
Kyung-A Kim
DooA Kim
Jonathan Hernandez
Virginia Pascual
Todd E. Heaton
Michael P. La Quaglia
David Kelsen
Tanya M. Trippett
David R. Jones
William R. Jarnagin
Irina R. Matei
Haiying Zhang
Ayuko Hoshino
David Lyden
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
STAR Protocols
Cell culture
Cell isolation
Cell Membrane
Exosomes
Exomeres
Extracellular vesicles and particles
title Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
title_full Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
title_fullStr Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
title_full_unstemmed Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
title_short Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
title_sort extracellular vesicle and particle isolation from human and murine cell lines tissues and bodily fluids
topic Cell culture
Cell isolation
Cell Membrane
Exosomes
Exomeres
Extracellular vesicles and particles
url http://www.sciencedirect.com/science/article/pii/S2666166720302124
work_keys_str_mv AT lindabojmar extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT hansangkim extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT gabrielctobias extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT fannyapelissiervatter extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT serenalucotti extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT kofiennugyan extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT candiamkenific extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT zurongwan extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT kyungakim extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT dooakim extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT jonathanhernandez extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT virginiapascual extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT toddeheaton extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT michaelplaquaglia extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT davidkelsen extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT tanyamtrippett extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT davidrjones extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT williamrjarnagin extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT irinarmatei extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT haiyingzhang extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT ayukohoshino extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids
AT davidlyden extracellularvesicleandparticleisolationfromhumanandmurinecelllinestissuesandbodilyfluids